373 related articles for article (PubMed ID: 34733609)
1. Relationship between Th17 immune response and cancer.
Marques HS; de Brito BB; da Silva FAF; Santos MLC; de Souza JCB; Correia TML; Lopes LW; Neres NSM; Dórea RSDM; Dantas ACS; Morbeck LLB; Lima IS; de Almeida AA; Dias MRJ; de Melo FF
World J Clin Oncol; 2021 Oct; 12(10):845-867. PubMed ID: 34733609
[TBL] [Abstract][Full Text] [Related]
2. The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment.
Pan Y; Yang W; Tang B; Wang X; Zhang Q; Li W; Li L
Front Immunol; 2023; 14():1192303. PubMed ID: 37457739
[TBL] [Abstract][Full Text] [Related]
3. The role of T helper 17 and regulatory T cells in tumor microenvironment.
Najafi S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.
Marshall EA; Ng KW; Kung SH; Conway EM; Martinez VD; Halvorsen EC; Rowbotham DA; Vucic EA; Plumb AW; Becker-Santos DD; Enfield KS; Kennett JY; Bennewith KL; Lockwood WW; Lam S; English JC; Abraham N; Lam WL
Mol Cancer; 2016 Oct; 15(1):67. PubMed ID: 27784305
[TBL] [Abstract][Full Text] [Related]
5. Protective role of the novel cytokine Metrnl/ interleukin-41 in host immunity defense during sepsis by promoting macrophage recruitment and modulating Treg/Th17 immune cell balance.
Chen X; Chen X; Yang Y; Luo N; Yang J; Zhong L; Guo T; Yuan Z; Wei Q; Wang C
Clin Immunol; 2023 Sep; 254():109690. PubMed ID: 37423488
[TBL] [Abstract][Full Text] [Related]
6. The paradox of Th17 cell functions in tumor immunity.
Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
[TBL] [Abstract][Full Text] [Related]
7. Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective.
Rezalotfi A; Ahmadian E; Aazami H; Solgi G; Ebrahimi M
Front Oncol; 2019; 9():226. PubMed ID: 31024835
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives.
Seif F; Torki Z; Zalpoor H; Habibi M; Pornour M
Mol Ther Oncolytics; 2023 Mar; 28():132-157. PubMed ID: 36816749
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Kinoshita M; Kobayashi S; Gotoh K; Kubo M; Hayashi K; Iwagami Y; Yamada D; Akita H; Noda T; Asaoka T; Takeda Y; Tanemura M; Eguchi H; Urakawa S; Goto K; Maekawa K; Wada H; Mori M; Doki Y
Dig Dis Sci; 2020 Oct; 65(10):2937-2948. PubMed ID: 31853779
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
11. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
12. Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy.
Chen C; Gao FH
Front Immunol; 2019; 10():187. PubMed ID: 30800130
[TBL] [Abstract][Full Text] [Related]
13. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
Stadhouders R; Lubberts E; Hendriks RW
J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
[TBL] [Abstract][Full Text] [Related]
14. Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment.
Xing J; Man C; Liu Y; Zhang Z; Peng H
Front Immunol; 2023; 14():1224269. PubMed ID: 37680632
[TBL] [Abstract][Full Text] [Related]
15. Initiative action of tumor-associated macrophage during tumor metastasis.
Singh S; Mehta N; Lilan J; Budhthoki MB; Chao F; Yong L
Biochim Open; 2017 Jun; 4():8-18. PubMed ID: 29450136
[TBL] [Abstract][Full Text] [Related]
16. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.
Seebauer CT; Brunner S; Glockzin G; Piso P; Ruemmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S; Kesselring R
Oncoimmunology; 2016; 5(12):e1242543. PubMed ID: 28439450
[No Abstract] [Full Text] [Related]
18. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
19. [The role of Th17 cells in anti-cancer immunity].
Hus I; Maciag E; Roliński J
Postepy Hig Med Dosw (Online); 2010 May; 64():244-50. PubMed ID: 20498501
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 and type 17 helper T cells in cancer management and research.
Llosa NJ; Geis AL; Thiele Orberg E; Housseau F
Immunotargets Ther; 2014; 3():39-54. PubMed ID: 27471699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
